Medisorb | Strategy, M&A and Transformation Advisory goetzpartners brings CapMan on board – and Medisorb becomes Russia's largest maker of generic drugs goetzpartners successfully brought together the Russian family-run pharmaceutical company Medisorb with CapMan, a Finnish private equity fund worth 2.8 billion euros. CapMan’s minority interest enabled Medisorb to triple its production capacity and grow from being the largest maker of generic drugs in the region of Perm to being the largest in Russia. From preparation to contract conclusion To open Medisorb’s doors to the international investment scene, goetzpartners’ advisers helped the company restructure its accounting system to meet international standards. This step quickly revealed Medisorb to be an attractive company for investmen

Join for free to read